| pubmed-article:8044687 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0019564 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C1545588 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0071174 | lld:lifeskim |
| pubmed-article:8044687 | lifeskim:mentions | umls-concept:C0220903 | lld:lifeskim |
| pubmed-article:8044687 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8044687 | pubmed:dateCreated | 1994-8-30 | lld:pubmed |
| pubmed-article:8044687 | pubmed:abstractText | Binding of a peripheral benzodiazepine receptor ligand was used to quantify the reactive gliosis resulting from neuronal damage induced by systemic injections of kainic acid 7 days previously. The enhancement of binding in rat hippocampus could be prevented by injections of the purine analogue (R)-N6-phenylisopropyladenosine at 25 microgram/kg up to 2 h before or after the toxin. These results indicate that the purine is able to prevent neurotoxicity by interrupting events occurring some time after kainate administration. | lld:pubmed |
| pubmed-article:8044687 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8044687 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8044687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8044687 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8044687 | pubmed:issn | 0361-9230 | lld:pubmed |
| pubmed-article:8044687 | pubmed:author | pubmed-author:StoneT WTW | lld:pubmed |
| pubmed-article:8044687 | pubmed:author | pubmed-author:MillerW JWJ | lld:pubmed |
| pubmed-article:8044687 | pubmed:author | pubmed-author:MacGregorD... | lld:pubmed |
| pubmed-article:8044687 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8044687 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:8044687 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8044687 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8044687 | pubmed:pagination | 133-6 | lld:pubmed |
| pubmed-article:8044687 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:meshHeading | pubmed-meshheading:8044687-... | lld:pubmed |
| pubmed-article:8044687 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8044687 | pubmed:articleTitle | Time course of purine protection against kainate-induced increase in hippocampal [3H]-PK11195 binding. | lld:pubmed |
| pubmed-article:8044687 | pubmed:affiliation | Department of Pharmacology, University of Glasgow, Scotland. | lld:pubmed |
| pubmed-article:8044687 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8044687 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
